aflac inc. - AFL
AFL
Close Chg Chg %
110.24 1.48 1.34%
Closed Market
111.72
+1.48 (1.34%)
Volume: 1.33M
Last Updated:
Nov 21, 2024, 3:59 PM EDT
Company Overview: aflac inc. - AFL
AFL Key Data
| Open $110.82 | Day Range 110.42 - 112.33 |
| 52 Week Range 75.08 - 115.50 | Market Cap $61.24B |
| Shares Outstanding 555.53M | Public Float 499.51M |
| Beta 0.96 | Rev. Per Employee N/A |
| P/E Ratio 16.60 | EPS $6.67 |
| Yield 174.17% | Dividend $0.50 |
| EX-DIVIDEND DATE Nov 20, 2024 | SHORT INTEREST N/A |
| AVERAGE VOLUME 2.06M |
AFL Performance
| 1 Week | -0.97% | ||
| 1 Month | 0.45% | ||
| 3 Months | 2.70% | ||
| 1 Year | 32.92% | ||
| 5 Years | 104.19% |
AFL Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
17
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | HOLD | Average Target Price | 105.692 | |
| Number of Ratings | 17 | Current Quarters Estimate | 1.634 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 7.174 | |
| Last Quarter’s Earnings | 2.16 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 6.23 | Next Fiscal Year Estimate | 7.172 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 13 | 12 | 15 | 15 |
| Mean Estimate | 1.63 | 1.78 | 7.17 | 7.17 |
| High Estimates | 1.67 | 1.91 | 7.31 | 7.70 |
| Low Estimate | 1.58 | 1.66 | 6.42 | 6.79 |
| Coefficient of Variance | 1.67 | 3.81 | 3.45 | 3.27 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 2 | 2 | 2 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 10 | 10 | 10 |
| UNDERWEIGHT | 1 | 1 | 1 |
| SELL | 3 | 3 | 3 |
| MEAN | Hold | Hold | Hold |
SEC Filings for Aflac Inc. - AFL
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Aflac Inc. - AFL
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Jun 26, 2024 | Virgil R. Miller President, Aflac U.S. | 7,729 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $90.43 per share | 698,933.47 |
| May 23, 2024 | Charles Ditmars Lake Chairman & Rep. Director, ALIJ | 61,522 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $87.47 per share | 5,381,329.34 |
| May 23, 2024 | Charles Ditmars Lake Chairman & Rep. Director, ALIJ | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| May 23, 2024 | Charles Ditmars Lake Chairman & Rep. Director, ALIJ | 83,900 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $30.72 per share | 2,577,408.00 |
| May 10, 2024 | Joseph L. Moskowitz Director | 27,550 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $84.84 per share | 2,337,342.00 |
| May 9, 2024 | Katherine T. Rohrer Director | 20,480 | Bona fide gift | 0.00 |
| May 9, 2024 | Katherine T. Rohrer Director | 21,380 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 9, 2024 | Miwako Hosoda Director | 5,656 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 9, 2024 | William Paul Bowers Director | 66,842 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 8, 2024 | Karole F. Lloyd Director | 47,036 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 8, 2024 | Arthur R. Collins Director | 7,732 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 8, 2024 | Nobuchika Mori Director | 12,526 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 8, 2024 | Georgette D. Kiser Director | 17,518 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 8, 2024 | Thomas J. Kenny Director | 20,046 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 6, 2024 | Max K. Brodén EVP, Chief Financial Officer | 235 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $76.31 per share | 17,932.85 |
| May 6, 2024 | Max K. Brodén EVP, Chief Financial Officer | 330 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 6, 2024 | Max K. Brodén EVP, Chief Financial Officer | 260 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 18, 2024 | Albert A. Riggieri SVP, Global CRO | 32,825 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $83.34 per share | 2,735,635.50 |
| Feb 23, 2024 | Daniel Paul Amos Chairman of the Board, CEO; Director | 798,187 | Bona fide gift | 0.00 |
| Feb 20, 2024 | Masatoshi Koide Pres. and Rep. Director, ALIJ | 116,583 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Aflac Inc. in the News
Aflac CEO says company adapted to health care in a 'post-COVID world'
The insurance industry has made some changes in the wake of COVID-19, and as patients needs evolve with time and medical recommendations, Aflac CEO Dan Amos said.
Aflac CEO says inflation is impacting Americans’ ability to afford ‘higher costs of health care’
Aflac Chairman and CEO Dan Amos says the insurance company will offer a higher premium policy "option" as inflation takes control of Americans' "purse strings."